 |
|
The voice for pharmacy compounding | October 2, 2020
|
THIS EDITION SPONSORED BY ChemoGLO
|  |
Did you know that ChemoGLO's wipe kit can test for 7 hormone drugs and 17 hazardous drugs? ChemoGLO is a company that's passionate about providing a healthier, safer work environment for both patients and healthcare workers.
| |
The ChemoGLO Wipe Kit and our HDClean Wipes can be used in any location where there is a risk of harmful exposure to hazardous drugs due to drug preparation and administration. Both products are USP800 compliant and meet requirements for testing for hazardous drugs and for deactivating, decontaminating, and cleaning drugs. For product and ordering questions, contact our sales team at 877-215-2705 Ext. 2 or visit www.chemoglo.com.
|
 |
From the President
|  Shawn Hodges
APC President |
For APC, the future is full of possibilities.
We're working on a handful of ideas focused on your success as a pharmacy compounder, and though none of them are quite ready for prime-time just yet, I thought you might appreciate a peek behind the curtain at what we're considering:
- A first-of-its-kind, real-world patient-reported compounding data collection and analytics platform for your compounding pharmacy.
- Seeking Pharmacy Compounding Foundation funding for a third-party scientific analysis of the NASEM cBHT study aimed at illuminating its (many) flaws.
- A consumer-focused media campaign aimed at reinforcing the role and value of pharmacy compounding in the American healthcare system (with cBHT as a major talking point).
- An online certificate program on the ethical, legal and regulatory framework of compounding - to provide compounding team members with essential introductory-level training.
- Hosting an in-person Compounding Pharmacy Owner Summit in early spring 2021 with a focus on business planning, best practices, and idea exchange.
- A company (versus individual) APC membership model in which for one flat dues amount, all of a pharmacy's employees would be members.
Not all of these may come to pass, but there's no doubt APC is considering the possibilities ... and working hard.
Read on for this week's compounding news....
Yours In Health,
Shawn
You can reach Shawn at shodges@innovationcompounding.com. |
 |
|
A Tricare recoupment reprieve?
Certainly a more reasonable position
It's looking like APC and NCPA have negotiated a reprieve for pharmacies hit by the recent Tricare recoupment. A confirmation letter from ESI is in the works and should provide clarity, we're told. When that's mailed, APC will host another briefing call on the issue. Sorry for the tease, but until it's confirmed, that's all we can say. Stay tuned.
|
USP BUD open forum recap
If you missed the USP Open Forum on BUD provisions in <795> & <797>, the recording is available
The presentation from the event is now available on USP's Healthcare Quality & Safety Stakeholder Forum Web page.
USP says it will now "compile all comments and questions and share them with the Compounding Expert Committee for their consideration and deliberation."
|
We've updated our USP state-by-state resource
Keep up with your state's position on USP chapters <795>, <797>, or <800>. We've updated our members only resource page on which states have adopted <795>, <797> or <800> -- or even which PARTS they've adopted, and what the state laws mean. Check out our "Compilation of State-Adopted USP 795, 797, 800 Rules" (login required, of course).
|
 |  |
Run for the foundation board
Nominations are open
The Pharmacy Compounding Foundation is seeking compounding professionals who want to advance the practice of pharmacy compounding as board members of the foundation.
The foundation serves as the charitable extension of APC and is used to conduct educational and scientific programming and research. Its mission is to advance pharmacy compounding practice and the profession for the benefit of patients. Its vision is to enhance patients' quality of life with compounded medications.
Interested candidates may self-nominate by clicking here. The deadline for nominations is Thursday, October 15, 2020.
|
 |
ICYMI
CCHV ain't over. Compounders on Capitol Hill is still going on -- we're in the midst of our 55 virtual congressional meetings. Fighting the Tricare clawbacks, getting a better MOU for states, seeing the animal-compounding GFI withdrawn, and keeping that flawed NASEM study from influencing policy -- those are the issues we're talking with key members of Congress about ... and we've got their attention. Don't forget to check out the issue briefs we've put together so you can stay informed.
Keep those cBHT stories coming! We've hit more than 1,250 so far, but we'd like even more. Share your testimonials and tell your patients: We need to show Congress and FDA how important compounded hormone therapy is to millions of patients. Go to A4PC.org/cbhtandme and fill out the simple form -- tell us what cBHT has meant to you!
|
|
|
|
|
|
|
|
|
|
|
|
